INTEGRATED CORE STRATEGIES (US) LLC - 26 Jun 2025 SCHEDULE 13G Report for Tenax Therapeutics, Inc. Common Stock, par value $0.0001 per share (TENX)

Filing Manager
INTEGRATED CORE STRATEGIES (US) LLC
Reporting Manager
Millennium Management LLC
Security
Tenax Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
TENX
Shares outstanding
4,171,714 shares
Disclosed Ownership
233,616 shares
Ownership
5.6%
Form type
SCHEDULE 13G
Filing time
30 Jun 2025, 16:34:17 UTC
Date of event
26 Jun 2025
Next filing
05 Nov 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"INTEGRATED CORE STRATEGIES (US) LLC disclosed 5.6% ownership in Tenax Therapeutics, Inc. Common Stock, par value $0.0001 per share (TENX) on 26 Jun 2025."

Quick Takeaways

  • INTEGRATED CORE STRATEGIES (US) LLC filed SCHEDULE 13G for Tenax Therapeutics, Inc. Common Stock, par value $0.0001 per share (TENX).
  • Disclosed ownership: 5.6%.
  • Date of event: 26 Jun 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 30 Jun 2025, 16:34.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Integrated Core Strategies (US) LLC 5.6% 233,594 0 233,594 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Management LLC 5.6% 233,616 0 233,616 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Group Management LLC 5.6% 233,616 0 233,616 /s/ Gil Raviv Gil Raviv, Global General Counsel
Israel A. Englander 5.6% 233,616 0 233,616 /s/ Israel A. Englander Israel A. Englander

Sponsored